Acute promyelocytic leukemia: a model of molecular target based therapy.
about
Developmental and genetic modulation of arsenic biotransformation: a gene by environment interaction?Drug metabolism by tumours: its nature, relevance and therapeutic implications.Molecular and chromosomal alterations: new therapies for relapsed acute myeloid leukemia.NLS-RARα is a novel transcriptional factor.
P2860
Acute promyelocytic leukemia: a model of molecular target based therapy.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Acute promyelocytic leukemia: a model of molecular target based therapy.
@ast
Acute promyelocytic leukemia: a model of molecular target based therapy.
@en
type
label
Acute promyelocytic leukemia: a model of molecular target based therapy.
@ast
Acute promyelocytic leukemia: a model of molecular target based therapy.
@en
prefLabel
Acute promyelocytic leukemia: a model of molecular target based therapy.
@ast
Acute promyelocytic leukemia: a model of molecular target based therapy.
@en
P2860
P1433
P1476
Acute promyelocytic leukemia: a model of molecular target based therapy
@en
P2093
Sai-Juan Chen
P2860
P304
P356
10.1080/10245330512331390519
P478
10 Suppl 1
P577
2005-09-01T00:00:00Z